Form 4: Fortive Corp Director Daniel L Comas Reports Acquisition of Shares and Stock Options

Director Daniel L Comas reports acquisition of Fortive Corp shares and stock options as part of an annual equity grant.

Summary

• On June 3, 2024, Daniel L Comas, a director of Fortive Corp, reported the acquisition of 1,970 shares of common stock and 1,990 director stock options.
• The common stock was acquired through restricted stock units (Annual Grant RSUs) granted by the issuer as part of the annual equity grant.
• The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting.
• The director stock options have an exercise price of $72.95 and expire on June 3, 2034.
• Following the reported transactions, Comas directly owns 45,279 shares of common stock and 1,990 director stock options.
• Comas also indirectly owns 1,721 shares through a spouse and 75 shares through irrevocable trusts.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The filing reflects a standard equity grant to a director, indicating confidence in the company's future. There are no negative implications.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future performance.
• The vesting schedule of the RSUs aligns the director's interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements, but the equity grant suggests an expectation of continued service and contribution from the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates that a director received an annual equity grant, which is a common practice in publicly traded companies.

Comparison to Industry Standards

• Equity grants to directors are a standard practice in publicly traded companies like Fortive Corp.
• Companies such as Danaher (DHR) and Agilent Technologies (A) also provide equity-based compensation to their directors and executives.
• The size and vesting schedule of the grant are typical for director compensation packages in similar large-cap industrial companies.

Stakeholder Impact

• The equity grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The increased ownership stake of the director may signal confidence to the market, potentially impacting shareholder value positively.

Next Steps

• The underlying shares of the restricted stock units will be delivered upon vesting, which will occur on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders.

Key Dates